Embecta EMBC
NASDAQ EMBC
$5.23 -0.24 (-4.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Embecta (EMBC) Cash & Equivalents (2022 - 2026)

Embecta (EMBC) posted Cash & Equivalents of $184.9 million for Q1 2026, down 8.15% sequentially from $201.3 million in Q4 2025, and down 11.66% YoY from $209.3 million in Q1 2025.

Embecta (EMBC) Cash & Equivalents (2022 - 2026) Analysis & Trends

Embecta has reported Cash & Equivalents for 5 years, with the latest figure at $184.9 million in Q1 2026.

  • Quarterly Cash & Equivalents fell 11.66% year-over-year to $184.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.9 million (down 11.66% YoY) and the FY2025 annual result came in at $225.5 million, down 15.7% from the prior year.
  • Cash & Equivalents fell to $184.9 million in Q1 2026 per EMBC's latest filing, from $201.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $385.2 million in Q4 2022 and troughed at $184.9 million in Q1 2026.
  • A 5-year average of $274.4 million and a median of $275.1 million in 2024 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2023 and 2025: Cash & Equivalents jumped 31.06% in 2023, then slumped 30.19% in 2025.
  • Over 5 years, Cash & Equivalents stood at $385.2 million in 2022, then declined by 22.46% to $298.7 million in 2023, then retreated by 29.7% to $210.0 million in 2024, then slipped by 4.14% to $201.3 million in 2025, then retreated by 8.15% to $184.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $184.9 million, $201.3 million, and $225.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 2.76 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 708.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 1.36 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 1.47 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 2.33 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 435.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 403.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 138.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 2.15 Bn
10 Embecta 305.26 Mn 87.06 Mn 153.30 Mn 214.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 214.70 Mn
Mar 31, 2026 184.90 Mn
Dec 31, 2025 201.30 Mn
Sep 30, 2025 225.50 Mn
Jun 30, 2025 230.60 Mn
Mar 31, 2025 209.30 Mn
Dec 31, 2024 210.00 Mn
Sep 30, 2024 267.50 Mn
Jun 30, 2024 275.10 Mn
Mar 31, 2024 299.80 Mn
Dec 31, 2023 298.70 Mn
Sep 30, 2023 326.30 Mn
Jun 30, 2023 317.40 Mn
Mar 31, 2023 346.40 Mn
Dec 31, 2022 385.20 Mn
Sep 30, 2022 330.90 Mn
Jun 30, 2022 292.30 Mn
Mar 31, 2022 264.30 Mn